Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -259,622 | -138,375 | 490,663 | 469,250 | 78,816 |
| Depreciation Amortization | 225,912 | 51,710 | 40,891 | 36,220 | 27,662 |
| Income taxes - deferred | 11 | 754,942 | 42,318 | 46,904 | -5,464 |
| Accounts receivable | 14,359 | 84,395 | -22,272 | -70,391 | -33,144 |
| Accounts payable and accrued liabilities | 723 | 5,284 | -1,578 | 676 | 1,176 |
| Other Working Capital | -12,614 | 97,844 | -45,082 | -176,631 | 35,893 |
| Other Operating Activity | 38,696 | -729,576 | 31,037 | 62,542 | 47,248 |
| Operating Cash Flow | $7,465 | $126,224 | $535,977 | $368,570 | $152,187 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -29,658 | -65,553 | -17,090 | -14,302 | 9,092 |
| Net Acquisitions | N/A | -69,622 | -238,349 | 119,957 | -3,024 |
| Purchase Of Investment | -1,500 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -300 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 6,842 | 12,865 | -12,173 | 0 | 0 |
| Investing Cash Flow | $-24,316 | $-122,310 | $-267,612 | $105,655 | $6,068 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 953 | N/A | 8,455 | N/A | 609,000 |
| Debt Repayment | -235,026 | -5,772 | -13,895 | -6,000 | -412,076 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 1,758,932 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -1,467,122 |
| Other Financing Activity | -1,639 | -55,318 | -182,059 | -153,049 | -435,522 |
| Financing Cash Flow | $-235,712 | $-61,090 | $-187,499 | $-159,049 | $53,212 |
| Exchange Rate Effect | N/A | N/A | N/A | -88 | 17 |
| Beginning Cash Position | 574,962 | 632,138 | 551,272 | 236,184 | 24,700 |
| End Cash Position | 322,399 | 574,962 | 632,138 | 551,272 | 236,184 |
| Net Cash Flow | $-252,563 | $-57,176 | $80,866 | $315,088 | $211,484 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,465 | 126,224 | 535,977 | 368,570 | 152,187 |
| Capital Expenditure | -29,658 | -65,553 | -17,090 | -14,850 | -25,408 |
| Free Cash Flow | -22,193 | 60,671 | 518,887 | 353,720 | 126,779 |